Page last updated: 2024-08-23

nedocromil and Left Ventricular Dysfunction

nedocromil has been researched along with Left Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janicki, JS; Jubair, S; Li, J1

Other Studies

1 other study(ies) available for nedocromil and Left Ventricular Dysfunction

ArticleYear
Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:2

    Topics: Animals; Cardiomyopathy, Hypertrophic; Cell Degranulation; Cell Size; Chymases; Collagen; Estradiol; Estrogen Replacement Therapy; Female; Hypertrophy, Left Ventricular; Mast Cells; Myocardium; Myocytes, Cardiac; Nedocromil; Oligopeptides; Organ Size; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling

2015